MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1172/jci179436

Медицинская библиотека · The Journal of clinical investigation · 2024

Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells.

Hwang Angelina S, Kechter Jacob A, Do Tran H, Hughes Alysia N, Zhang Nan, Li Xing, Bogle Rachael, Brumfiel Caitlin M, Patel Meera H, Boudreaux Blake, Bhullar Puneet, Nassir Shams, Yousif Miranda L, Stockard Alyssa L, Leibovit-Reiben Zachary, Ogbaudu Ewoma, DiCaudo David J, Fox Jennifer, Gharaee-Kermani Mehrnaz, Xing Xianying, Zunich Samantha, Branch Emily, Kahlenberg J Michelle, Billi Allison C, Plazyo Olesya, Tsoi Lam C, Pittelkow Mark R, Gudjonsson Johann E, Mangold Aaron R

СтатьяКлиническое исследование II фазыПеревод в очереди

Аннотация

BACKGROUNDCutaneous lichen planus (LP) is a recalcitrant, difficult-to-treat, inflammatory skin disease characterized by pruritic, flat-topped, violaceous papules on the skin. Baricitinib is an oral Janus kinase (JAK) 1/2 inhibitor that interrupts the signaling pathway of IFN-γ, a cytokine implicated in the pathogenesis of LP.METHODSIn this phase II trial, 12 patients with cutaneous LP received 2 mg daily baricitinib for 16 weeks, accompanied by in-depth spatial, single-cell, and bulk transcriptomic profiling of pre- and posttreatment samples.RESULTSAn early and sustained clinical response was seen, with 83.3% of patients responsive at week 16. Our molecular data identified a unique, oligoclonal IFN-γ, CD8+, and CXCL13+ cytotoxic T cell population in LP skin and demonstrated a rapid decrease in IFN signature within 2 weeks of treatment, most prominently in the basal layer of the epidermis.CONCLUSIONThis study demonstrates the efficacy and molecular mechanisms of JAK inhibition in LP.TRIAL REGISTRATIONNCT05188521FUNDINGEli Lilly, Appignani Benefactor Funds, 5P30AR075043, Mayo Clinic Clinical Trials Stimulus Funds.

Для цитирования: Hwang Angelina S, Kechter Jacob A, Do Tran H, Hughes Alysia N, Zhang Nan, Li Xing, Bogle Rachael, Brumfiel Caitlin M, Patel Meera H, Boudreaux Blake, Bhullar Puneet, Nassir Shams, Yousif Miranda L, Stockard Alyssa L, Leibovit-Reiben Zachary, Ogbaudu Ewoma, DiCaudo David J, Fox Jennifer, Gharaee-Kermani Mehrnaz, Xing Xianying, Zunich Samantha, Branch Emily, Kahlenberg J Michelle, Billi Allison C, Plazyo Olesya, Tsoi Lam C, Pittelkow Mark R, Gudjonsson Johann E, Mangold Aaron R. Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells.. The Journal of clinical investigation. 2024. DOI: 10.1172/jci179436.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.